Browsing by Author Arkenau, Hendrik-Tobias

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2014Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF-inhibitor Dabrafenib (GSK2118436)Kefford, Richard (Rick); Long, Georgina; Arkenau, Hendrik-Tobias; Brown, Michael P.; Chin, Melvin; et al, .; Falchook, Gerald; Hamid, Omid; Infante, Jeffrey; Kim, Kevin; Kurzrock, Razelle; Millward, Michael; Pavlick, Anna C.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreDose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF-inhibitor Dabrafenib (GSK2118436), Clinical Cancer Research, vol.20, 17, 2014,pp 4449-4458
2013Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)Barnetson, Ross; China, Carlos; Cho, Eun-Ae; Damian, Diona; Halliday, Gary; Moloney, Fergal; Arkenau, Hendrik-Tobias; Au-Yeung, Annie; Cai, Hong; Deng, Jason Z; et al, Various; Francis, Douglas J; Hammond, Paula T; Morton, Stephen W; Raftery, Mark J.; Scolyer, Richard A; Yosufi, Benafsha; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Dermatology Research Foundat.Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER), The Lancet, vol.381, 9880, 2013,pp 1835-1843
2016Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancerHui, Rina; Arkenau, Hendrik-Tobias; Cappuzzo, F; Chatterjee, M; Dong, D; et al, .; Felip, E; Garon, Edward; Gubens, Matthew; Hellmann, M D; Horn, Leora; Lena, H; Li, C; Mayawala, K; Turner, D C; Western Clinical School: Medicine (Westmead)Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer, Annals of Oncology, vol.27, 7, 2016,pp 1291-1298
2013Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)Kefford, Richard (Rick); Long, Georgina; Arkenau, Hendrik-Tobias; D'Andrea, Kurt; et al, Various; Falchook, Gerald; Greshock, Joel; Infante, Jeffrey; Letrero, Richard; Martin, Anne-Marie; Millward, Michael; Nathanson, Katherine L.; O'Day, Steven; Wubbenhorst, Bradley; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer CentreTumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436), Clinical Cancer Research, vol.19, 17, 2013,pp 4868-4878